Details for New Drug Application (NDA): 211851
✉ Email this page to a colleague
The generic ingredient in EFINACONAZOLE is efinaconazole. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the efinaconazole profile page.
Summary for 211851
Tradename: | EFINACONAZOLE |
Applicant: | Padagis Us |
Ingredient: | efinaconazole |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 10% | ||||
Approval Date: | Dec 16, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription